GlassScriptPhysician profile
Shaigan Iqbal
NPI 1568849438
$5,800.36
in general payments reported to CMS, 2019-2025
22 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,043 · 2021: $1,464 · 2022: $1,204 · 2023: $397 · 2024: $416 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,088.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,821.47 | 2020-2025 | Varithena Administration Pack, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $934.17 | 2021-2024 | Eterna |
| Nevro Corp. | $481.95 | 2020-2023 | Senza |
| Collegium Pharmaceutical, INC. | $374.82 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $295.82 | 2020-2021 | |
| Si-Bone, INC. | $165.87 | 2020-2022 | |
| Redhill Biopharma INC. | $121.76 | 2021 | |
| Medtronic, INC. | $95.02 | 2021 | |
| Biodelivery Sciences International, INC. | $87.58 | 2020-2021 | |
| Nuvasive, INC. | $80.28 | 2020 | |
| Scilex Pharmaceuticals INC. | $68.92 | 2020-2021 | |
| Grt US Holding, INC. | $53.00 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $45.74 | 2020-2021 | |
| Avanos Medical | $29.78 | 2023 | Trivisc Sodium Hyaluronate |
| Biogen, INC. | $26.46 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $25.90 | 2021 | |
| Forte Bio-Pharma LLC | $19.13 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.88 | 2025 | |
| Ibsa Pharma INC. | $14.84 | 2021 | |
| Nalu Medical, INC. | $14.55 | 2021 | |
| Mdd US Operations, LLC | $12.94 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaigan Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.